[Caution] hepatic endpoints need biopsy data, not an ALT screenshot
Confession thread, sort of. I went from 1.0mg to 15mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 17 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have muscle…
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
Flair changed to match the content. Read the sidebar before posting next time and we are square.
the safety profile is not just tirzepatide amplified
MASH claims need the trial and the biopsy endpoint
the safety profile is not just tirzepatide amplified
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
do not generalise from tirzepatide
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.